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Abstract 21 
 22 
Diacetyl is a volatile flavour compound that has a characteristic buttery aroma and is widely 23 
used in the flavour industry. The aroma of a food plays an important role in food palatability 24 
and thus intake. This study investigates the effect of diacetyl on the satiety hormone, 25 
glucagon-like peptide (GLP-1), using the enteroendocrine cell line, STC-1. Diacetyl 26 
decreased proglucagon mRNA and total GLP-1 from glucose stimulated STC-1 cells. This 27 
dampening effect on GLP-1 appears to be mediated by increasing intracellular cAMP levels, 28 
increasing synthesis of the G protein coupled receptor, GPR120, and its recruitment to the 29 
cell surface. Voltage gated Ca2+ channels, K+ATP channels and the α–gustducin taste pathway 30 
do not appear to be involved. These findings demonstrate that components contributing to 31 
food palatability suppress GLP-1. This ability of diacetyl to reduce satiety signals may 32 
contribute to overconsumption of some palatable foods. 33 
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1. Introduction 45 
The gut hormone glucagon-like peptide 1 (GLP-1) has attracted considerable interest in 46 
recent years due to its ability to enhance glucose-dependent insulin secretion, promote 47 
pancreatic β-cell proliferation and reduce food intake. It has also been reported that GLP-1 48 
may reduce the rewarding and reinforcing properties of palatable foods (Dickson, Shirazi, 49 
Hansson, Bergquist, Nissbrandt, & Skibicka, 2012). Secretion of this nutrient-responsive 50 
hormone is impaired in obesity and type 2 diabetes (Toft-Nielsen, et al., 2001) and infusion 51 
of GLP-1 has been shown to improve glycemia and reduce food intake in obese patients 52 
(Nauck, et al., 1998).  53 
GLP-1 is produced by L cells of the distal jejunum and ileum following tissue-specific 54 
proteolytic processing of the proglucagon gene (Baggio & Drucker, 2007). The arrival of 55 
carbohydrate, fat and protein in the gut lumen triggers GLP-1 release (Bruen, O'Halloran, 56 
Cashman, & Giblin, 2012). Inhibition of GLP-1 by food has not been extensively studied. 57 
Within the L cells, GLP-1 secretion occurs in response to an increase in intracellular levels of 58 
cyclic adenosine monophosphate (cAMP) and Ca2+ (Tolhurst, Reimann, & Gribble, 2009). 59 
Changes in these mediators are brought about by nutrient uptake pathways, metabolic 60 
closures of potassium channels and/or activation of nutrient-responsive G protein-coupled 61 
receptors (GPCRs) (Reimann, et al., 2012). These GPCRs play various roles in GLP-1 62 
secretion. The taste GPCRs, T1r3/T1r2, and the G protein α-gustducin are involved in the 63 
secretion of GLP-1 in response to sugars (Jang, et al., 2007). On the other hand, free fatty 64 
acids (FFA) can induce GLP-1 secretion via the GPCRs, GPR40 and GPR120 (Hirasawa, et 65 
al., 2005; Reimann, et al., 2012). GPR120 is highly expressed in enteroendocrine L cells 66 
(Anbazhagan, et al., 2016; Hirasawa, et al., 2005) and is activated in response to unsaturated 67 
long-chain free fatty acids (FFAs) (Tanaka, Yano, Adachi, Koshimizu, Hirasawa, & 68 
Tsujimoto, 2008). Recent evidence also suggests that GPR120 plays an important role in the 69 
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orosensory detection and preference for fats (Cartoni, et al., 2010). GPR120 is classified as a 70 
Gq/11-coupled receptor, capable of increasing GLP-1 secretion via phospholipase Cβ and 71 
intercellular Ca2 signalling (Blad, Tang, & Offermanns, 2012) although there is also some 72 
evidence of signalling promiscuity (Reimann, et al., 2012; Tsukahara, et al., 2015).  73 
While the role of taste receptors and tastants in GLP-1 secretion has been widely investigated 74 
in recent years, there is less information available on whether aromatic compounds may also 75 
influence satiety signals. The aroma of a food plays an important role in food palatability and 76 
intake (Massolt, van Haard, Rehfeld, Posthuma, van der Veer, & Schweitzer, 2010; 77 
Ruijschop, Boelrijk, de Graaf, & Westerterp-Plantenga, 2009). While such effects may be 78 
mediated through neural pathways, it is also possible that aroma compounds may influence 79 
satiety signals. Indeed, it has been demonstrated that food-derived odorants present in the gut 80 
lumen may stimulate serotonin release via olfactory receptors present in human 81 
enterochromaffin cells (Braun, Voland, Kunz, Prinz, & Gratzl, 2007) and aroma intensity 82 
certainly influences perceived satiation (Ruijschop, et al., 2009).  83 
Diacetyl (2,3-butanedione) is a volatile favour compound that occurs naturally in several 84 
foods, such as butter, milk, cheese, fruit and coffee and has a characteristic buttery aroma 85 
(Bartowsky & Henschke, 2004). It is primarily produced by citrate fermenting lactic acid 86 
bacteria during pyruvate metabolism. It is widely used in the flavouring industry. This 87 
pleasant buttery aroma is perceived as a positive attribute by consumers and has been shown 88 
to play a significant role in food preference and palatability (Liggett, Drake, & Delwiche, 89 
2008).  90 
The present study was undertaken to evaluate whether diacetyl alters GLP-1 production and 91 
secretion, using the murine secretin tumor cell line (STC-1). STC-1 is a popular and reliable 92 
enteroendocrine model to investigate gut hormone production and secretion. Similar to native 93 
L cells, STC-1 cells secrete GLP-1 in response to sugars, peptides, fatty acids, sweeteners, 94 
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bitter tastants, food bioactives, hormones  and bile  (McCarthy, Green, Calderwood, 95 
Gillespie, Cryan, & Giblin, 2015). However levels of response may differ to the native state 96 
(Kuhre, et al., 2016). STC-1 cells also express GPR120, taste receptors (T1r1, T1r2, T1r3) 97 
and α-gustducin (Hirasawa, et al., 2005; Wu, Rozengurt, Yang, Young, Sinnett-Smith, & 98 
Rozengurt, 2002) and are recognized as a good model for taste signalling (Saitoh, Hirano, & 99 
Nishimura, 2007).  100 
 101 
 102 
2. Materials and methods 103 
2.1. Chemicals 104 
Diacetyl (2,3 butanedione), KREBS ringers bicarbonate buffer, nicardipine, nitrendipine, 105 
tolbutamide, pertussis toxin, polyethylene glycol, DMSO, Hanks Balanced Salt Solution, 106 
DMEM media, glucose, L-glutamine, Foetal Bovine Serum, penicillin, streptomycin, 3-107 
Isobutyl-1-methylxanthine (IBMX), forskolin, poly-l-lysine coated glass-slides, 108 
paraformaldehyde, HEPES, NaCl, EDTA, ethylene glycol tetraacetic acid, Nonident P40, 109 
dithiothreitol, Na3VO4, phenylmethysulphonyl fluoride, aprotinin, leupeptin, NaF, NaPPi, 110 
Tris-HCL, SDS, glycerol, bromophenol blue, Tween-20, Phosphate Buffered Saline (PBS), 111 
Tris buffered saline, Triton X-100, paraformaldehyde, Bovine Serum Albumin (BSA), 112 
donkey serum and β-actin horseradish peroxidase antibody were all sourced from Sigma 113 
Aldrich, Ireland. Alpha-linolenic acid was sourced from Cayman Europe, Estonia. Glyoxyl 114 
buffer was sourced from Ambion, USA. Rabbit anti-GPR120 antibody was purchased from 115 
Life Span Biosciences, USA. Donkey anti-rabbit Alexa 488 antibody was purchased from 116 
Santa Cruz Biotechnology, USA and horseradish peroxidase-conjugated anti-rabbit IgG was 117 
purchased from Jackson Immunoresearch, USA. Alamar Blue, NuPAGE 4-12 % Bis-Tris 118 
Gels and TOPO-TA cloning kit were purchased from Invitrogen, USA. QIAzol Lysis 119 
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Reagent Qiagen miRNeasy Mini Kit, QIAquick PCR Purification Kit and QuantiTect reverse 120 
transcription kit were sourced from Qiagen, UK. LightCycler 480 SYBR Green I Master kit 121 
was sourced from Roche Diagnostics, Germany. Halt Protease and Phosphatase Inhibitor 122 
were purchased from Thermo Fisher Scientific, USA. Total GLP-1 MSD® metabolic assay 123 
was purchased from Meso Scale Discovery, USA. The cAMP HTRF kit was purchased from 124 
Cisbio Bioassays, France. Pierce Biotechnology, USA supplied the BCA protein assay kit 125 
and the chemiluminescence Western blotting Substrate Kit. Polyvinylidene difluoride 126 
membranes were purchased from BIO-RAD, France. Non-fat dry milk and skim milk were 127 
purchased from Marvel, Premier Foods Limited, UK.  128 
Stock solution of nicardipine (5 mM) was prepared in polyethylene glycol. Stock solution of 129 
nitrendipine (1 mM) was prepared in DMSO. Tolbutamide stock solution was prepared in 130 
DMSO at a concentration of 100 mM. Stock solution of Pertussis toxin (50 µg/ml) was 131 
prepared in distilled H2O. All test compounds were prepared fresh, immediately before 132 
experiments in KREBS Ringers bicarbonate buffer (0.0468 g/l MgCl2, 0.34 g/l KCl, 7 g/l 133 
NaCl, 0.1 g/l Na2HPO4, 0.18 g/l NaH2PO4, 1.8 g/l D-glucose, 1.26 g/l NaHCO3) unless stated 134 
otherwise. Alpha-linolenic acid (100 µM) was prepared in pre-warmed KREBS and sonicated 135 
to aid solubility.  136 
 137 
2.2. STC-1 exposure to diacetyl and blockers 138 
STC-1 was received as a kind gift from by Prof. B. Wice (Washington University, St. Louis, 139 
USA) with permission from Prof. D. Hanahan (Swiss Institute for Experimental Cancer 140 
Research, Switzerland). STC-1 cells were cultured in DMEM containing 4.5 g/l of glucose 141 
and L-glutamine and supplemented with 17.5 % foetal bovine serum, 100 U/ml of penicillin 142 
and 100 mg/l of streptomycin. Cells were passaged upon reaching 80-90 % confluence. 143 
Experiments were performed with cells at passage numbers 15-30 (Gonzalez-Abuin, 144 
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Martinez-Micaelo, Blay, Green, Pinent, & Ardevol, 2014). STC-1 cells were seeded into 6-145 
well plates at a density of 1.5 x 106 cells/well and incubated at 37 °C, 5 % CO2, for 18 h prior 146 
to exposures. Cell monolayers in each well were washed with KREBS (1 ml) and then pre-147 
incubated for 1 h with KREBS (500 µl). Following the pre-incubation period, KREBS was 148 
aspirated off and replaced with 1 ml of diacetyl, freshly prepared in KREBS, at various 149 
concentrations. Cells were exposed to diacetyl solution for 10 min, 30 min, 1 h, 2 h, 3 h and 4 150 
h in sealed plates at 37 °C, 5 % CO2. STC-1 cells were incubated with the blocker of interest 151 
for 15 min prior to exposure to 1000 ppb of diacetyl for a further 4 h. The final working 152 
concentrations of the blockers, prepared in KREBS buffer, were as follows: 5 µM nicardipine 153 
and nitrendipine, 100 µM tolbutamide and 10 µg/ml pertussis toxin, as previously described 154 
(Chen, Wu, Reeve, & Rozengurt, 2006; McLaughlin, Lomax, Hall, Dockray, Thompson, & 155 
Warhurst, 1998; Ristoiu, Pluteanu, Flonta, & Reid, 2002).  156 
 157 
2.3. Cellular viability 158 
Following the 1 h pre-incubation step in 10 µl of KREBS, 100 µl of various concentrations of 159 
diacetyl (500 ppb, 1000 ppb and 2000 ppb) were added to 1 x 105 STC-1 cells/well. Alamar 160 
Blue (10 µl) was added to each well and the plate was incubated for 4 h at 37 °C. 161 
Fluorescence was measured at 570 nm. STC-1 cell viability in the presence of each blocker 162 
was also tested. Data were expressed as % viability of STC-1 cells exposed to test 163 
compounds compared to STC-1 cells exposed to KREBS alone. 164 
 165 
2.4. Real time-PCR 166 
Following exposures, cell monolayers were washed with 1 ml of Hanks Balanced Salt 167 
Solution. Cells were then lysed, using QIAzol Lysis Reagent and total RNA was isolated 168 
from cell suspensions using the Qiagen miRNeasy Mini Kit, according to the manufacturer’s 169 
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instructions. Total RNA was quantified spectrophotometrically, using the Nanodrop 1000 170 
(Thermo Fisher Scientific, USA) and the integrity assessed by electrophoresis in a 1.5 % 171 
glyoxyl gel with 1 X glyoxyl buffer. Complementary DNA was prepared from 1 µg of RNA, 172 
using the Qiagen QuantiTect reverse transcription kit. Real time PCR was performed in a 173 
LightCycler 480 instrument (Roche Diagnostics, Germany) to quantify proglucagon (of 174 
which exon 4 codes for GLP-1), GPR40 and GPR120 mRNA levels. All primers were 175 
designed across intron/exon boundaries. Primers for murine proglucagon were designed, 176 
based on the GenBank sequence (accession Z46845): Forward primer 5’ -177 
AGGGACCTTTACCAGTGATGTGA- 3’, Reverse primer 5’- 178 
ACGAGATGTTGTGAAGATGGTTGT -3’. The annealing temperature for amplification 179 
was 56 °C. Primers for murine GPR40 were designed, based on the Genbank sequence 180 
(accession AB095745): Forward Primer 5’ –TGCCCGTCTCAGTTTCTCCATTC- 3’, 181 
Reverse primer 5’ –TGTTCCCAAGTAGCCAGTGACCAG- 3’. Primers for murine GPR120 182 
were designed, based on the Genbank Sequence (accession AY288424): Forward primer 5’ 183 
GGCCCAACCGCATAGGAGAAAT- 3’, Reverse primer 5’ –184 
TGAAGGCCACCACCCAGAAGAAAA- 3’. The annealing temperature for amplification 185 
for GPR40 and GPR120 primers was 50 °C. Plasmid standards for proglucagon were created 186 
by cloning an amplified PCR product into the pCR4-TOPO vector, using the TOPO-TA 187 
cloning system, according to the manufacturer’s instructions. Standards for GPR40 and 188 
GPR120 were created from amplified PCR products, which were purified using a QIAquick 189 
PCR Purification Kit, according to the manufacturer’s instruction. The cloned amplicon and 190 
PCR products were confirmed by sequencing (Beckman Coulter Genomics, UK). For RT-191 
PCR standards, linearized plasmid DNA or PCR products were quantified, using the 192 
Nanodrop 1000 (Thermo Fischer Scientific, USA), and a series of dilutions from 109 to 193 
102copies were generated. For each 10 µl of Lightcycler reaction, 1 µl of test cDNA or 194 
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serially-diluted standard was used. The LightCycler 480 SYBR Green I Master kit was used 195 
for quantification, using 0.5 µM concentrations of both the forward and reverse primers.  196 
 197 
2.5. Secretion studies of Total GLP-1 198 
Following the incubation period, 10 µl of 10 X Halt Protease and Phosphatase Inhibitor were 199 
added to each well to inactivate endogenous dipeptidyl peptidase-4 activity. The cellular 200 
supernatants were collected by aspiration and stored at -80 °C prior to analysis. Cellular 201 
supernatant levels of total GLP-1 were assayed, using an MSD® metabolic assay, according 202 
to the manufacturer’s instructions. The MSD assay reports a minimum detection limit of 0.3 203 
pM of total GLP-1. Total GLP-1 concentrations (pM) in the samples were quantified by 204 
interpolating the intensity of emitted light from standard curves generated in the same assays. 205 
 206 
2.6. cAMP accumulation assay 207 
Intracellular cAMP levels were measured, using a cAMP HTRF kit, according to 208 
manufacturer’s instructions. Briefly STC-1 cells were seeded into a 96-well plate at a density 209 
of 6 x 105 cells/ml and incubated overnight at 37 °C, 5 % CO2. Medium was aspirated off and 210 
the cell monolayers were washed with 100 µl of KREBS supplemented with 1 mM IBMX. 211 
The cells were incubated for 30 min in 25 µl of KREBS-IBMX solution. Cells were then 212 
exposed to 25 µl of diacetyl (1000 ppb) for a further 30 min. The positive control used was 1 213 
µM forskolin, a known activator of the enzyme adenylyl cyclase, which causes an increase in 214 
intracellular cAMP. The negative control was KREBS-IBMX solution alone. After treatment, 215 
the reactions were stopped by addition of lysis buffer containing homogeneous time-resolved 216 
fluorescence reagents. Plates were then incubated for 60 min at room temperature, and time-217 
resolved fluorescence resonance energy transfer signals were measured, using a FLUOstar 218 
Omega microplate reader (BMG Labtech, Germany).  219 
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 220 
2.7. Immunocytochemistry 221 
For immunocytochemistry, STC-1 cells were seeded at a density of 8 x105 cells/ml in 24 well 222 
plates containing poly-l-lysine-coated glass-slides and incubated overnight at 37 °C, 5 % CO2 223 
prior to exposure to diacetyl (1000 ppb) or α−linolenic acid (100 µM) for 30 min, 1 h and 4 224 
h. As a control, cells were exposed to KREBS alone for the same time intervals. Following 225 
exposure, cells were fixed with 4 % paraformaldehyde in PBS for 20min and permeabilized 226 
in PBS supplemented with 0.1 % Triton X-100 for 5 min. Slides were than blocked with 10 227 
% donkey serum diluted in PBS supplemented with 0.1 % Triton X-100. The slides were then 228 
incubated overnight with rabbit anti GPR120 antibody (1:500 dilution), after which the slides 229 
were washed and incubated for 2 h at room temperature with donkey anti-rabbit Alexa 488 230 
antibody (1:1000). Primary and secondary antibodies were prepared in PBS supplemented 231 
with 0.1 % Triton X-100 and 1 % donkey serum. Specificity of GPR120 antibody was 232 
confirmed by the absence of fluorescent staining in HEK293T cells which do not express the 233 
GPR120 receptor (Tanaka, Yano, Adachi, Koshimizu, Hirasawa, & Tsujimoto, 2008). 234 
Specificity of the secondary antibody was confirmed by the absence of fluorescent staining 235 
when the primary antibody was omitted (data not shown). Slides were analyzed, using an 236 
inverted microscope set-up with a sensitive XM10 camera with an infrared cut filter, mercury 237 
burner and fluorescence condenser (Olympus, Japan). Pictures were processed using Cell^F 238 
Imaging Software (Olympus, Japan). For fluorescence data, intensity was determined to be 239 
the mean pixel intensity for the entire cell using Image J software (National Institutes of 240 
Health, USA). Staining was conducted in triplicate and, from an image of each staining; five 241 
individual cells were selected for fluorescence intensity analysis.  242 
 243 
2.8. Western blotting 244 
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STC-1 cells were seeded into 12-well plates at a density of 1.5 x 106 cells/well and incubated 245 
at 37 °C, 5 %CO2, for 18 h prior to exposures. Following a 30 min, 1 h or 4 h exposure to 246 
KREBS alone, 1000 ppb of diacetyl or 100 mM α-linolenic acid, cells were lysed with lysis 247 
buffer (50 mM HEPES, 150 mM NaCl, 1 mM EDTA, 1 mM ethylene glycol tetraacetic acid, 248 
1 % Nonident P40, 0.5 mM dithiothreitol and 0.1 mM Na3VO4) containing protease inhibitors 249 
(0.1 mM phenylmethysulphonyl fluoride, 2 µg aprotinin/ml, 2 µg of leupeptin/ml, 0.02 mM 250 
NaF and 0.025 mM NaPPi) and centrifuged at 12,000 g for 10 min to remove insoluble 251 
debris. Protein content of the lysates was quantified using a BCA kit. The cell lysate was 252 
diluted in 4 X sample buffer (333 mM Tris-HCl, 3 % SDS, 26.7 % glycerol, 130 mM 253 
dithiothreitol and 0.2 % bromophenol blue) and heated for 10 min at 95 °C. Samples were 254 
loaded at 20 µg of protein per lane onto precast NuPAGE 4–12 % Bis-Tris Gels. The 255 
separated proteins were transferred onto polyvinylidene difluoride membranes by 256 
electroblotting. The membrane was blocked for 1.5 h with Tris buffered saline solution 257 
containing 0.1 % Tween-20 supplemented with 3 % non-fat dry milk and 2 % BSA. 258 
Membranes were incubated overnight at 4 oC with rabbit anti GPR120 antibody (1:1,000 259 
dilution) in 0.1% Tween-20 supplemented with 1 % skim milk and 1 % BSA. After three 260 
washes in 0.1% Tween-20, the membranes were incubated for 1.5 h at room temperature with 261 
horseradish peroxidase-conjugated anti-rabbit IgG (1:8,000). Visualisation was performed, 262 
using the enhanced chemiluminescence Western blotting Substrate Kit and GelDoc Image 263 
Reader (Las3000; Fujifilm, Japan). Sample loading of protein was corrected by staining with 264 
a 1:15,000 dilution of a β-actin horseradish peroxidase antibody. 265 
 266 
2.9. Statistical analysis 267 
STC-1 cell exposures to vehicle control (KREBS), diacetyl and blockers were performed in 268 
duplicate and on two separate occasions. For cellular viability assays, at least 2 wells on two 269 
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separate occasions were examined per test compound. RT-PCR assays were performed in 270 
triplicate. Total GLP-1 assays were performed in duplicate with both technical and 271 
experimental repeats. 272 
Data were analysed by one-way analysis of variance (ANOVA), followed by, where 273 
appropriate, Fishers least significant difference (LSD) multiple comparison posthoc test. 274 
Means without a common letter differ significantly from each other (P<0.05). 275 
 276 
 277 
3. Results  278 
 279 
3.1. Diacetyl reduces proglucagon mRNA levels and total GLP-1 secretion in the presence of 280 
10mM glucose 281 
STC-1 cells were exposed to physiologically relevant concentrations of the volatile flavour 282 
compound, diacetyl. As in other studies (Zhou & Pestka, 2015), exposures were performed in 283 
the presence of the known stimulator, glucose. In our study, experiments were performed in 284 
KREBS Ringers bicarbonate buffer, which contains 10 mM glucose. Exposure of STC-1 cells 285 
to diacetyl resulted in a significant (P < 0.05) dose-dependent decrease in proglucagon 286 
mRNA levels compared to the vehicle control at all timepoints (Figure 1A). Increasing the 287 
exposure time from 10 min to 4 h led to an overall reduction in proglucagon mRNA levels 288 
(Figure 1A). This reduction in proglucagon mRNA coincided with a significant (P < 0.05) 289 
decrease in secreted levels of total GLP-1 compared with the control (Figure 1B). In STC-1 290 
cells, the presence of diacetyl reduces proglucagon transcription and total GLP-1 secretion in 291 
response to glucose. In order to address potential cytotoxicity of diacetyl to STC-1 cells, the 292 
Alamar Blue assay was employed which is based on the ability of viable cells to reduce 293 
resazurin to resorufin. There was no significant difference in the ability of cells to reduce 294 
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resazurin to resorufin in the presence of various concentrations of diacetyl compared to 295 
vehicle control (Figure 2). These results indicated that diacetyl suppression of GLP-1 296 
production and secretion is not due to cytotoxicity. GC/MS analysis of cellular supernatant 297 
after 4 h exposure to diacetyl revealed that this volatile compound was still present in the 298 
supernatant, albeit at a reduced level (data not shown). 299 
 300 
3.2. Is diacetyl suppression of total GLP-1 mediated via K+, Ca2+ channels, taste pathways or 301 
intracellular cAMP? 302 
To investigate whether the reduction of transcript levels of proglucagon mRNA by diacetyl 303 
was mediated through Ca2+ channels, glucose stimulated STC-1 cells were preincubated with 304 
L-type voltage-dependent Ca2+ channel blockers, nicardipine and nitrendipine, prior to 305 
exposure to diacetyl. Both failed to restore proglucagon mRNA levels to those observed with 306 
KREBS (Figure 3A). Indeed in both cases, there was a further small yet significant reduction 307 
(P < 0.05) in proglucagon mRNA levels compared with exposure to diacetyl alone. 308 
Preincubation with the K+ channel blocker, tolbutamide, followed by exposure to diacetyl, 309 
failed to restore proglucagon mRNA levels to vehicle control (Figure 3A). To examine if the 310 
effects of diacetyl were mediated through taste signalling pathways, glucose stimulated STC-311 
1 cells were incubated in the presence of pertussis toxin, a known blocker of the α-subunit of 312 
gustducin prior to exposure to diacetyl (Figure 3A). Blocking α-gustducin resulted in a 58-313 
fold decrease in proglucagon mRNA levels in glucose stimulated STC-1 cells compared with 314 
the vehicle control and 17-fold decrease compared with levels observed with diacetyl (Figure 315 
3A). These observed decreases were not as a result of decreases in cellular viability in the 316 
presence of the various blockers (data not shown). 317 
Secreted levels of total GLP-1 were measured in STC-1 cells stimulated with glucose in the 318 
presence of the various blockers (data not shown). Nicardipine increased levels of secreted 319 
  
14 
 
total GLP-1 from glucose stimulated STC-1 cells by 2-fold (P < 0.05). GLP-1 levels 320 
remained unchanged with nitrendipine compared with vehicle control. STC-1 cells secreted 321 
significantly more GLP-1 in the presence of tolbutamide (P < 0.05) compared with glucose 322 
alone (vehicle control). Pertussis toxin had no effect on GLP-1 levels. To determine if the 323 
various blockers could block the inhibition of diacetyl on secreted GLP-1 levels, STC-1 cells 324 
were preincubated with each individual blocker prior to diacetyl exposure. None of the 325 
blockers were capable of altering levels of secreted GLP-1 from glucose-stimulated STC-1 326 
cells exposed to diacetyl (Figure 3B).  327 
The failure to respond to tolbutamide in a diacetyl background may indicate that diacetyl 328 
exposure causes cAMP levels to rise in STC-1 cells, closing KATP-channels (Reimann, 2010). 329 
Intracellular cAMP was therefore measured in a competitive immunoassay. Glucose-330 
stimulated STC-1 cells exposed to 1000 ppb of diacetyl had a 5-fold increase in intracellular 331 
cAMP compared with cells incubated with glucose alone (Figure 4).  332 
 333 
3.3. Diacetyl increases GPR120 mRNA levels and cell surface expression 334 
As diacetyl is a methyl ketone and is structurally similar to methyl ketones produced during 335 
oxidation of free fatty acids, we investigated if GPR40 and GPR120 responded to diacetyl 336 
presence. Diacetyl had no significant effect on mRNA levels of the medium- to long-chain 337 
fatty acid receptor, GPR40, in glucose-stimulated STC-1 cells (Figure 5A). However, mRNA 338 
levels of the long chain fatty acid receptor, GPR120, were significantly (P < 0.05) increased 339 
in glucose-stimulated STC-1 cells exposed to diacetyl compared with KREBS (Figure 5B). 340 
To explore whether GPR120 proteins levels were also affected by diacetyl, time-course 341 
experiments was performed by immunofluorescent staining and Western blotting. Exposure 342 
of glucose-stimulated STC-1 cells, over a 4 h period, to diacetyl significantly (P < 0.05) and 343 
progressively increased GPR120 levels, both at protein and cell surface level, compared with 344 
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vehicle control (Figure 6). These increases with 1000 ppb of diacetyl (which equates to 11.7 345 
µM) were also significantly higher than those observed with the GPR120 agonist, α-linolenic 346 
acid (100 µM), indicating that diacetyl is more potent. 347 
 348 
 349 
4. Discussion 350 
The widely used flavour ingredient diacetyl inhibits production and secretion of GLP-1 by 351 
intestinal endocrine cells in vitro. This damping effect on GLP-1 appears to be mediated by 352 
recruiting GPR120 to the cell surface, increasing intercellular cAMP levels and increasing 353 
GPR120 synthesis. The mechanism of GLP-1 reduction by diacetyl appears to be 354 
electroneutral, as evidenced by independence from K+ATP channels and voltage-gated Ca2+ 355 
channels. The α–gustducin taste pathway also does not appear to be involved in response to 356 
this flavour compound. Whether diacetyl enters the cell is unknown.  357 
Diacetyl is structurally similar to methyl ketones produced during oxidation of free fatty 358 
acids. Ketones produced in this manner are mainly derived from fatty acids with 6 to 12 359 
carbons. This may thus explain the ability of diacetyl to interact with GPR120. GPR120 is 360 
classified as a Gq protein-coupled free fatty acid (Blad, et al., 2012) that is internalized in the 361 
presence of long chain free fatty acids with concomitant increase in cytosolic Ca2+ but with 362 
no effect on cAMP levels (Hirasawa, et al., 2005). However, with the knowledge that 363 
GPR120 also plays roles in apoptosis (Katsuma, et al., 2005) and inflammatory response in 364 
intestinal L cells (Anbazhagan, et al., 2016; Tsukahara, et al., 2015), there is growing 365 
evidence that GPR120 can couple to alternative downstream pathways (Iakoubov, Izzo, 366 
Yeung, Whiteside, & Brubaker, 2007; Tsukahara, et al., 2015). Tsukahara et al. (2015) have 367 
recently demonstrated that activation of GPR120 can inhibit proglucagon production via Gs 368 
cAMP pathway in inflamed rat L cells and GLUTag cells (Tsukahara, et al., 2015). Treatment 369 
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of L-cells with 10 ng/ml of TNF-α, a pro-inflammatory cytokine, resulted in a 50 % decrease 370 
in proglucagon mRNA transcript levels. This effect was mediated by upregulating GPR120 371 
and increasing cellular levels of cAMP. Similar to diacetyl, 30 ng/ml of TNF had no effect on 372 
the GPR40 mRNA transcript whilst increasing GPR120 mRNA by 250 % (Tsukahara, et al., 373 
2015). Although the inflammatory status of STC-1 cells exposed to diacetyl, a GRAS food 374 
additive, was not monitored, cell viability was not altered. 375 
In our study, STC-1 cells incubated with 1000 ppb of diacetyl resulted in 518 % increase in 376 
cAMP levels with a 70 % inhibition of proglucagon transcription and 93 % reduction in 377 
GLP-1 exocytosis compared with KREBS alone. Elevation of cAMP levels in STC-1 cells 378 
usually enhances transcription of proglucagon (Gevrey, et al., 2004; Islam, et al., 2009; Lotfi, 379 
et al., 2006). The proglucagon promoter contains a cAMP response element (CRE) at -291 bp 380 
to -298 bp. Increase in cAMP levels, leads to activation of the enzyme protein kinase A 381 
(PKA) which phosphorylates CRE-binding protein (CREB). Phosphorylated CREB then 382 
binds to other transcription factors (e.g. Pax-6, Isl-1) and usually recruits them to the 383 
promoter in order to bridge the pre-initiation complex (Gevrey, et al., 2004). In STC-1 cells, 384 
site-directed mutagenesis of the CRE site causes a 50 % reduction in the ability of forskolin 385 
to increase proglucagon promoter activity (Gevrey, et al., 2004). In GLUTag cells, cAMP 386 
rise by 10 µM; forskolin/IBMX stimulates GLP-1 exocytosis (Simpson, et al., 2007) but 387 
surprisingly does not increase GLP-1 exocytosis in STC-1 cells (Kuhre, et al., 2016). In 388 
GLUTag cells, this GLP-1 exocytosis is mediated through PKA phosphorylation of Kir6.2, 389 
the pore-forming subunit of K+ channels (Reimann, 2010). This results in channel closure and 390 
an increase in intracellular Ca2+, either via influx into the cell through voltage-gated Ca2+ 391 
channels or by mobilisation of intracellular Ca2+ stores (Reimann, 2010). In our study, neither 392 
the L-type voltage-dependent Ca2+ channel blockers, nicardipine and nitrendipine, nor the K+ 393 
channel blocker, tolbutamide could influence the inhibitory effect of diacetyl on GLP-1 394 
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secretion, indicating differences in response to intracellular cAMP levels between GLUTag 395 
and STC-1 cells. 396 
The significant reduction by diacetyl of GLP-1 production in STC-1 cells in the presence of 397 
glucose appears to be specific, as neither the butterscotch fruity aroma, 2-butanone, nor the 398 
pineapple fruity odour, ethyl butyrate, altered proglucagon mRNA levels (unpublished data). 399 
However Jang et al. (2007) demonstrated that the food additive, lactisole, also significantly 400 
reduced GLP-1 secretion in sucrose-stimulated NCI-H716 cells (Jang, et al., 2007). Lactisole 401 
(2.5 mM) reduced GLP-1 secretion 1-fold in these human enteroendocrine cells incubated 402 
with 1-5mM sucrose compared to cells with sucrose alone (Jang, et al., 2007). Lactisole 403 
mediates its GLP-1 attenuation via the taste receptor, T1r3 (Jiang, et al., 2005) and is 404 
therefore added to food to suppress the perception of sweetness.  405 
Gonzalez-Abuin et al. (2014) reported that 50 mg/l of grape seed procyanidin extract (GSPE) 406 
significantly reduced secreted levels of active GLP-1 from STC-1 cells stimulated with either 407 
20 mM glucose or 5 mM proline plus 2.5 mM glucose (Gonzalez-Abuin, et al., 2014). 408 
Interestingly this flavonoid extract had no effect on GLP-1 secretion from STC-1 cells 409 
stimulated with 30 µM linoleic acid plus 10mm glucose (Gonzalez-Abuin, et al. 2014). GSPE 410 
appears to mediate its effect on STC-1 cells by the hyperpolarization of cellular and 411 
mitochondrial membranes, indicating that Na+ chelation at the cation channel, TRPM5, 412 
maybe involved (Gonzalez-Abuin, et al. 2014). GSPE is likely to be perceived as bitter with a 413 
negative sensory attribute. The neuropeptide, galanin (100 nM) can also inhibit GLP-1 414 
secretion by 75 % in primary duodenal cultures that are stimulated with 10 mM glucose and 415 
100 µM IBMX (Psichas, Glass, Sharp, Reimann, & Gribble, 2016). This 29 amino acid 416 
peptide appears to mediate its inhibitory effect on stimulated enterendocrine cells by 417 
activating its GAL1 receptor, employing Gi coupling pathways, reducing intercellular cAMP 418 
levels but not involving potassium channels (Psichas, et al., 2016). The nuclear receptor 419 
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Farnesoid X Receptor (FXR) is expressed in L-cells and activation of FXR in GLUTag cells 420 
resulted in a 50 % inhibition of glucose (5.6 mM)-induced proglucagon transcription 421 
(Trabelsi, et al., 2015). FXR physically interacts with the carbohydrate response element 422 
binding protein (ChREBP), implying that it interferes with ChREBP docking on the 423 
proglucagon promoter (Trabelsi, et al., 2015). Trabelsi et al. (2015) also observed that active 424 
FXR decreases glucose-induced GLP-1 secretion by inhibiting glycolysis and lowering 425 
intracellular ATP levels but not impeding membrane depolarization (Trabelsi, et al., 2015).  426 
Given the important role of GLP-1 in food intake and glucose homeostasis, it is surprising 427 
that the inhibition and fine-tuning of production and secretion of GLP-1 by foods has 428 
received little attention. To our knowledge, this is the first study which shows an inhibitory 429 
effect of a volatile aroma compound on satiety hormone production and secretion, albeit in 430 
vitro. Although there is extensive information available on (1) the mechanisms of neural 431 
responses to both orthonasal and retronasal aroma (Shirasu, et al., 2014), and (2) links 432 
between aroma, sensory exposure and satiation (Ruijschop, et al., 2009), there appears to be 433 
little information available on aroma directly modulating satiety signals. Massolt et al. (2010) 434 
did observe that subjects who smelled dark chocolate before eating it reported significantly 435 
higher levels of satiation, a result which correlated inversely with serum levels of the hunger 436 
hormone, ghrelin, but had no effect on serum GLP-1 (Massolt, et al., 2010). If the aroma of a 437 
food can dampen the gastrointestinal GLP-1 response to that food, the amount of that food 438 
consumed may increase. Overconsumption of palatable food is considered a major factor 439 
contributing to the global surge in obesity (Kenny, 2011).  440 
In conclusion, the results of our study demonstrate that diacetyl reduces levels of 441 
proglucagon mRNA transcripts and total GLP-1 secretion, with an associated increase in 442 
cAMP levels and recruitment of GPR120 to the cell surface. It is feasible that inhibition of 443 
GLP-1 by palatable food components can contribute to overconsumption.  444 
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Figure 1. GLP-1 production and secretion in STC-1 cells exposed to diacetyl. (A) STC-1 583 
cells (1.5 x 106 cells/well) were exposed to various concentrations of diacetyl in KREBS, 584 
which contains 10 mM glucose, from 10 min to 4 h. Different superscript letters (a-d) 585 
indicate significant proglucagon mRNA differences within the same exposure time (P<0.05). 586 
* indicates significant differences (P < 0.05) due to 500 ppb diacetyl after 10 min exposure 587 
compared with 4 h exposure. ‡ indicates significant differences (P < 0.05) due to 1000 ppb 588 
diacetyl after 10 min compared with 4 h. § indicates significant differences (P < 0.05) due to 589 
2000 ppb diacetyl after 10 min compared with 4 h. (B) STC-1 cells (1.5 x 106 cells/well) 590 
were exposed to 1000 ppb of diacetyl in KREBS for 4 h. Levels of total GLP-1 were 591 
quantified in cell supernatant. Different superscript letters indicate significant differences in 592 
total GLP-1 (P < 0.05). Both technical and experimental repeats were performed in duplicate 593 
on two separate occasions.  594 
 595 
  596 
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Figure 2. STC-1 cellular viability in the presence of various concentrations of diacetyl. 597 
Viability of STC-1 cells (1 x 105 cells/well) was determined, by Alamar Blue, after 598 
incubation for 4 h with diacetyl. KREBS alone was the vehicle control and represented 100 % 599 
cellular viability. Superscripts with a common letter are similar to each other (P > 0.05). Both 600 
technical and experimental repeats were performed in duplicate on two separate occasions.  601 
  602 
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Figure 3. GLP-1 production and secretion in STC-1 cells exposed to various blockers. 603 
(A) proglucagon mRNA levels: STC-1 cells (1.5 x 106 cells/well) were incubated with 604 
various blockers (Ca2+ channel blockers (5 µM nicardipine or 5 µM nitrendipine), K+channel 605 
blocker (100 µM tolbutamide) or the α-gustducin inhibitor (10 µg/ml pertussis toxin)) for 15 606 
min. Diacetyl (1000 ppb) was then added and cells incubated for a further 4 h. KREBS alone 607 
is the vehicle control. Superscripts with a different letter indicate a significant difference (P < 608 
0.05). (B) Secreted levels of total GLP-1. Different superscripts indicate significant 609 
differences (P < 0.05). 610 
  611 
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 612 
Figure 4. Intracellular cAMP levels in STC-1 cells exposed to 1000 ppb of diacetyl for 4 613 
h. Each value represents the mean ± SEM. Vehicle control was KREBS alone. Means 614 
without a common letter differ significantly from each other (P < 0.05).  615 
  616 
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 617 
Figure 5. (A) GPR40 mRNA levels and (B) GPR120 mRNA levels in STC-1 cells STC-1 618 
cells (1.5 x 106 cells/well) were exposed to 1000 ppb of diacetyl for 4 h. Means without a 619 
common letter differ significantly from each other (P < 0.05). 620 
 621 
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Figure 6. (A) GPR120 surface expression and (B) GPR120 protein levels in STC-1 cells. 624 
(A) For immunocytochemistry, seeded STC-1 cells (8 x 105 cells/ml) were exposed, for 30 625 
min, 1 h or 4 h, to either KREBS alone or 1000 ppb of diacetyl or 100 µM α- linolenic acid. 626 
Rabbit anti GPR120 (1:500 dilution) antibody was applied to fixed cells. Staining was 627 
conducted in triplicate and from an image of each staining, five individual cells were selected 628 
for fluorescence intensity analysis. Data at each time point were analysed, using a one-way 629 
ANOVA with a Fisher’s LSD comparison. Means without a common roman numeral, within 630 
the same time interval, differ significantly from each other (P < 0.05). (B) STC-1 cells were 631 
seeded into 12-well plates at a density of 1.5 x 106 cells/well and exposed for 30 min, 1 h or 632 
4h to KREBS alone, 1000 ppb of diacetyl or 100 mM α-linolenic acid. Separated proteins 633 
were incubated with rabbit anti GPR120 antibody (1:1,000 dilution). Sample loading of 634 
protein was corrected by staining with a 1:15,000 dilution β-actin horseradish peroxidase 635 
antibody. Both technical and experimental repeats were performed in duplicate on two 636 
separate occasions.  637 
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Highlights: 640 
• A volatile favour compound with a pleasant aroma supresses GLP-1, a satiety 641 
hormone 642 
• Aromatic diacetyl recruits GPR120 to the cell surface and increases cAMP levels  643 
• K+ATP channels, Ca2+ channels and the α-gustducin taste pathway are not involved 644 
  645 
 646 
